PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-1.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.47%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.44%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.16%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-48.39%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-53.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
133.94%
10Y revenue/share CAGR under 50% of ON's 268.43%. Michael Burry would suspect a lasting competitive disadvantage.
38.70%
5Y revenue/share CAGR under 50% of ON's 110.51%. Michael Burry would suspect a significant competitive gap or product weakness.
28.08%
3Y revenue/share CAGR under 50% of ON's 70.50%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
498.85%
10Y OCF/share CAGR 1.25-1.5x ON's 385.05%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
175.85%
5Y OCF/share CAGR above 1.5x ON's 97.90%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
116.94%
3Y OCF/share CAGR above 1.5x ON's 20.86%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
9620.45%
Net income/share CAGR above 1.5x ON's 439.04% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
187.69%
5Y net income/share CAGR above 1.5x ON's 119.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
83.48%
Below 50% of ON's 218.49%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
25.60%
Below 50% of ON's 287.63%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.65%
Negative 5Y equity/share growth while ON is at 127.64%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.64%
Negative 3Y equity/share growth while ON is at 94.30%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
597.21%
Dividend/share CAGR of 597.21% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
156.46%
Dividend/share CAGR of 156.46% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.64%
3Y dividend/share CAGR of 102.64% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
19.30%
AR growth well above ON's 2.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.88%
Inventory is declining while ON stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.79%
Positive asset growth while ON is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.87%
We have a declining book value while ON shows 2.38%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
21.41%
Debt growth far above ON's 0.13%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.75%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
No Data
No Data available this quarter, please select a different quarter.